Search by PDB author

High-resolution structure of the cemiplimab Fab in complex with PD-1
分子名称:	Programmed cell death protein 1, heavy chain, light chain
著者	Heo, Y.-S, Jeong, T.J.
登録日	2022-09-21
公開日	2023-10-04
実験手法	X-RAY DIFFRACTION (1.98 Å)
主引用文献	High-resolution structure of the cemiplimab Fab in complex with PD-1 To Be Published

High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine
分子名称:	caplacizumab, von Willebrand factor
著者	Lee, H.T, Heo, Y.-S.
登録日	2021-04-23
公開日	2021-07-07
最終更新日	2023-11-29
実験手法	X-RAY DIFFRACTION (1.6 Å)
主引用文献	High-resolution structure of the vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine for treating acquired TTP. Biochem.Biophys.Res.Commun., 567, 2021

crystal structure of CD38 in complex with daratumumab
分子名称:	ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, Heavy Chain, Light chain
著者	Lee, H.T, Heo, Y.S.
登録日	2020-11-13
公開日	2021-09-22
最終更新日	2023-11-29
実験手法	X-RAY DIFFRACTION (2.55 Å)
主引用文献	Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma. Biochem.Biophys.Res.Commun., 536, 2021

PD-1 in complex with Dostarlimab
分子名称:	Programmed cell death protein 1, heavy chain, light chain
著者	Heo, Y.S.
登録日	2022-01-30
公開日	2022-08-24
最終更新日	2023-11-29
実験手法	X-RAY DIFFRACTION (1.534 Å)
主引用文献	Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy. Biochem.Biophys.Res.Commun., 599, 2022